Journal of Spleen and Liver Research

Current Issue Volume No: 1 Issue No: 4

ISSN: 2578-2371
share this page

Research Article Open Access
  • Available online freely Peer Reviewed
  • Provisional

    Liver Disease: A Retrospective Hospital Based Study in Addis Ababa-Ethiopia

    Samson Erkabu 1   Bisrat Demeke 2   Hailu Desallegn 3   Selam Getachew 4  

    1Department of internal medicine, Ras Desta Damtew Memorial Hospital, Addis Ababa –Ethiopia

    2Department of internal medicine, Saint Paul Millennium Medical College, Addis Ababa-Ethiopia.

    Abstract

    Background

    Liver disease has caused significant morbidity and mortality worldwide. Its epidemiologic and clinical pattern, however, is not well characterized in sub-Saharan countries.

    Objective

    This study aimed to describe demographic, clinical characteristics, and patterns of liver disease in a community hospital in Addis Ababa, Ethiopia.

    Method

    A retrospective hospital-based study was conducted on patients with liver disease admitted at Ras Desta Damtew memorial hospital, in Addis Ababa-Ethiopia, from February 2015 to April 2020.

    Result

    Of the total 212 patients majority, 78.8% were male, 49.1% of patients were in the age range of 31-50 with a median age of 42. The most common initial clinical presentation was ascites (87.7 %), and more than half of patients (56.6%) had a history of alcohol misuse documented on their medical charts. Chronic liver disease (cirrhosis) was found in 177 (83.5%), and Hepatocellular Cancer accounted for 7.5% of the patients. Alcohol misuse caused 45% of chronic Liver Disease, followed by Hepatitis B virus infection.

    Conclusion

    Chronic liver disease is the most common form of liver disease, and the most affected were middle-aged men. The common cause of chronic liver disease was alcohol followed by hepatitis B virus infection.

    Author Contributions
    Received 28 Jul 2021; Accepted 21 Aug 2021; Published 25 Aug 2021;

    Academic Editor: Adil Khan, Pakistan

    Checked for plagiarism: Yes

    Review by: Single-blind

    Copyright ©  2021 Samson Erkabu, et al.

    License
    Creative Commons License     This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

    Competing interests

    The authors have declared that no competing interests exist.

    Citation:

    Samson Erkabu, Bisrat Demeke, Hailu Desallegn, Selam Getachew (2021) Liver Disease: A Retrospective Hospital Based Study in Addis Ababa-Ethiopia . Journal of Spleen And Liver Research - 1(4):1-7.

    Download as RIS, BibTeX, Text (Include abstract )

    DOI 10.14302/issn.2578-2371.jslr-21-3912

    Introduction

    Liver diseases, including chronic HBV and HCV infection, Alcoholic liver disease, Non-alcoholic fatty liver disease, Autoimmune liver disease, Drug-induced liver injury (DILI), and Hepatocellular cancer, affects a large population of individuals. It accounts for nearly 2 million deaths per year worldwide, 1 million due to cirrhosis-related complications and 1 million due to viral hepatitis and hepatocellular carcinoma. 1

    The incidence of liver disease is increasing; for instance, the estimated number of European Union citizens to live with chronic liver disease is half a million. 2According to National statistics in the United Kingdom, liver diseases have been ranked as the fifth most common cause of death 3, and in the United States, it is the second leading cause of mortality amongst all digestive diseases 4. In sub-Saharan Africa, cirrhosis-related death has doubled between 1980 to 2010 5. During 2001, the estimated worldwide mortality from cirrhosis was 771,000 people, ranking 14th and 10th as the leading cause of death in the world and developed countries, respectively 6.

    Alcohol contributes to 4% of liver-related mortality and 5% of disability-adjusted life years (DALY) globally, with the highest impact in Europe, where the mortality and DALY are 7% and 12%, respectively 8. In the United States, the proportion of alcohol-related liver deaths is still considerably large and comparable in scope to that of HCV 9.

    Primary liver cancer is the seventh most frequently occurring cancer worldwide; and the second most common cause of cancer mortality 10. The highest incidence rates are in Asia and Africa 11. Its causes include hepatitis B, C, and alcohol and accounted for 47, 23, and 20%, respectively. In the remaining 10%, the underlying etiology was not known 7.

    More than 1000 drugs have been associated with drug-induced liver injury (DILI), which can present in all forms of acute and chronic liver disease. The incidence of DILI is estimated to be 14 to 19 cases per 100,000 persons, with jaundice accompanying 30% of cases.12,13

    In Ethiopia, liver diseases accounted for 11.4% of all medical admissions. Viral hepatitis, post- hepatic and post necrotic and mixed cirrhosis, and hepatocellular carcinoma were the different patterns of the liver disease reported. Alcoholic cirrhosis was rare. 14

    Despite the hypothesized increase in the prevalence of liver disease in sub-Saharan African countries, factors for the occurrence of liver disease, clinical profiles, and outcomes of patients with liver disease are not well described. In Ethiopia, the same is true where the magnitude of liver disease, its morbidity, and mortality is not known. One reason for the lack of such meaningful data could be poor handling of medical records as an electronic medical recording system for clinical and vital events reporting is absent in most sub-Saharan countries. However, world health organization has been publishing data on burden of liver disease of countries worldwide; based on the latest data, liver disease attributed to 2.7 % of total deaths in Ethiopia in 2018.

    Objective

    This study aims to describe demographic, clinical characteristics, and patterns of liver disease in a community hospital in Addis Ababa, Ethiopia.

    Materials and Methods

    This retrospective hospital-based study was conducted on patients with liver disease admitted to Ras Desta Damtew memorial hospital (RDDMH) in Addis Ababa-Ethiopia from February 2015 to April 2020. The hospital has a total of 166 beds with six inpatient wards and 19 outpatient departments. It provides medical services for an estimated 4 million people.

    Patients below 18 years old, with incomplete medical records and inadequate investigations, were excluded from the study. From a total of 344 patients with liver disease, only 212 left for final analysis after exclusion.

    General practitioners were trained on the study objectives, and purposes including data collecting techniques. We used a pretested data-collecting tool to abstract data from the medical notes of the patients. The data collection process has been closely monitored by the principal investigator (S.E.). Data were collected to assess demographic variables (age, sex, and address), clinical presentations, and patterns of liver disease.

    Ethical approval was obtained from the RDDMH ethics committee. Written permission to conduct the study was granted from the hospital. Patient informed consent was not required as only anonymous and operational monitoring data were collected and analyzed.

    Data Analysis

    Data entered into SPSS Version 23 statistical package software (IBM Corp., Armonk, NY). According to the study objectives, we used frequencies and proportions to describe the subjects in relation to the studied variables; the results are presented with tables.

    Result

    During the specified study period, a total of 344 patients were documented to have liver disease on the health management information system (HMIS) logbooks and accounted for 3.81% of hospital admission. Of these 344 patients, only 212 had fulfilled the inclusion criteria with complete medical records for analysis. Among the 212 patients majority were male (78.8%), and 49.1% were in the age group of 31-50 with a median age of 42.

    The most common first clinical presentation was ascites (87.7 %) (Table 1) and more than half of patients (56.6%) had a history of alcohol misuse documented in the patient's medical charts. We found no documentation of parotid enlargement, spider naevi, and Dupuytren's contracture in all of the cases.

    Table 1. Demographic and clinical patterns of liver disease admitted at Ras Desta Damtew Memorial hospital, Addis Ababa-Ethiopia from February 2015 to April 2020
      Number of patients Percent % All patients (n=212)
    Age      
    18-30 45 21.2  
    31-50 104 49.1  
    51-65 45 21.2  
    >65 18 8.5  
    Sex      
    Male 167 78.8  
    Female 45 21.2  
    Residence      
    Addis Ababa 187 88.2  
    Oromia 20 9.4  
    Other 5 2.4  
    Clinical presentation      
    Ascites 186 87.7  
    Abdominal pain 172 81.1  
    Anorexia 170 80.2  
    Jaundice 141 66.5  
    Hepatic encephalopathy 89 41.2  
    Fever 59 27.8  
    Spontaneous bacterial peritonitis 53 25  
    Upper Gastrointestinal bleeding 51 24  
    Abdominal Mass 15 7.1  
    Pruritus 2 0.9  
    Hematologic profile      
    Normal 57 26.9  
    Anemia 53 25  
    Thrombocytopenia 39 18.4  
    Anemia + Thrombocytopenia 39 18.4  
    Leukocytosis 15 7.1  
    Pancytopenia 5 2.4  
    Thrombocytosis 4 1.9  
    Liver function test      
    Normal 35 16.5  
    Deranged 172 81.1  
    Type of Liver disease      
    Chronic liver disease 177 83.5  
    Hepatocellular carcinoma 16 7.5  
    Drug induced liver injury 11 5.2  
    Alcoholic hepatitis 5 2.4  
    Liver hemangioma 2 0.9  
    Hepatitis B carrier 1 0.5  

    More than 90% of these cases were labeled to have chronic liver disease (Table 1). Alcohol misuse has caused 45% of chronic liver disease, and the second common cause was hepatitis B virus infection (Table 2).

    Table 2. Causes of chronic liver disease in admitted patients at Ras Desta Memorial hospital from Addis Ababa, Ethiopia from February 2015 t0 April 2020
    NO Causes of Chronic Liver Disease Number of patients Percent %
    1 Alcohol 86 45
    2 Hepatitis B 39 20.4
    3 Hepatitis C 22 11.5
    4 Unclassified 25 13.1
    5 Hepatitis C + Alcohol 10 5.2
    6 Hepatitis B + Alcohol 8 4.2
    7 Hepatitis B + Hepatitis C 1 0.5

    Of the 11 patients who had a drug-induced liver injury (DILI), the culprit agents in 8 of the cases were anti-tuberculosis medications, and in the rest, the cause was the use of herbal medicines.

    While hematologic abnormality was documented in 73.1% of cases, hepatic encephalopathy was observed in only 42% of the patients, and 25% of the patients had spontaneous bacterial peritonitis.

    Although upper gastrointestinal bleeding was documented in 24.1 % of the patients, only 7.5% of these patients had undergone upper gastrointestinal endoscopy.

    While admitted to the hospital, 21.2% of the patients died.

    Discussion

    This hospital-based retrospective study has characterized the patterns of liver disease, clinical pictures, and hospital mortality rate of patients. Here we compare our findings with available studies.

    From this study, we observed that the most commonly affected age group is 31-50 years of age and the majority of cases are males. This finding is similar to studies done in different parts of the country. 15,16 If these observations are going to be repeated in future studies, the same age group could be a target for preventive measures.

    The most common pattern of liver disease found in this study was chronic liver disease (CLD), which accounts for 90.1% of all liver diseases. The global prevalence of cirrhosis from autopsy studies ranges from 4.5% to 9.5% of the general population 17,18,19. In Nigeria, there is also a high incidence of CLD with varying degrees of prevalence reported in different geopolitical areas across the country. 21 Our finding, however, is higher than a report from a study done two decades ago in 334 hospitalized adult Ethiopian patients with a liver disease where cirrhosis comprises only 62.3% of all cases. 20 One reason for this difference could be a demographic change of the country for the last few decades.

    In Ethiopia, the estimated seroprevalence of hepatitis B surface antigen (HBsAg) is 6.0% 22, and HCV-antibody (anti-HCV) is 3.1% 23. Our finding, however, showed Alcohol misuse as the common cause of CLD. This finding is also contrary to other findings where viral hepatitis infections were strongly associated with chronic liver disease 15,24 . In eastern Ethiopia, the predominant etiology of CLD was a toxic liver injury from the usage of Khat16. Though this difference needs further investigation, an observed increase in the misuse of alcohol in sub-Saharan countries could explain why alcohol is increasingly causing CLD25. Alcohol consumption is directly linked to life threatening liver diseases which may ultimately lead to death 29.

    Most of our patients come to the hospital with ascites, abdominal pain, jaundice, and anorexia for the first time. Clinical findings such as; Dupuytren’s contracture, parotid gland enlargement, and superficial vascular abnormalities were rarely documented. Other studies in Ethiopia also reported the absence of those symptoms14,16. These findings need further evaluation to conclude the clinical significance and utility of these symptoms in CLD patients in our setup.

    Spontaneous bacterial peritonitis occurs in up to 10% of adult CLD patients 30. In our study, however, the rate is higher. It is likely because of the low threshold and simplicity of using ascitic fluid analysis to diagnose spontaneous bacterial peritonitis.

    Antibiotics like amoxicillin-clavulanic acid and acetaminophen are common causes of drug-induced liver injury 26. Among 11 cases of DILI in our sample, eight were attributed for anti-tuberculosis medications, and the rest are a result of herbal medicines.

    Dual infection from HBV and HCV is a frequent occurrence in highly endemic areas; and among subjects with a high risk of parenteral infections 27. We found only one case where there is a dual infection of both HBV and HCV.

    In this study, 7.5 % of patients had hepatocellular cancer (HCC). Five out of eight patients had hepatitis B, and 4 of them were positive for Hepatitis C Virus. Another study in Ethiopia also reported hepatitis B and C viruses as a cause of HCC in 48% of the cases 28.

    Limitation

    We have excluded a significant percentage of patients from the study because of the poor handling of medical records. A missed data could have introduced random error, and patients missing data might systematically differ from those with complete data. Nevertheless, this study has described the clinical nature of patients with liver disease at a community hospital. The findings could help identify the gaps in the care of patients with liver disease in hospitals in Ethiopia.

    Conclusion

    All forms of liver disease were observed in this hospital-based study; chronic liver disease from different etiologies is the most common form of liver disease. Alcohol has caused the majority of cases, followed by hepatitis B infection. Except for a few peripheral stigmata of chronic liver disease, most were observed. Despite a higher rate of upper gastrointestinal bleeding, there is limited access to upper gastrointestinal endoscopy. This has hindered the proper characterization of those patients with upper gastrointestinal bleeding. The majority of patients affected are productive age groups of the society; this warrants a preventive strategy towards the occurrence of liver diseases.

    Acknowledgment

    The authors gratefully acknowledge the assistance of the hospital and data collection staff at the health institution.

    Availability of Data and Material

    The data that support the findings of this study are available from the corresponding author upon reasonable request.

    References

    1.Asrani S K, Devarbhavi H, Eaton J, Kamath P S. (2019) Burden of liver diseases in the world. J Hepatol. 70(1), 151-171.
    2.Blachier M. (2013) The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol.
    3.. UK national statistics, http://www.statistics.gov.uk/
    4.Everhart J E, Ruhl C E. (2009) Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas. , Gastroenterology 136, 1134-1144.
    5.Mokdad A A, Lopez A D, Shahraz S. (2014) Liver cirrhosis mortality in 187 countries between1980and2010:a systematic analysis. , BMC Med 12, 145.
    6.Mathers C, Lopez A, Murray C. (2006) The burden of disease and mortality by condition: data, methods, and results for 2001. In: Lopez A, Mathers C, Ezzati M, et al, editors. Global burden of disease and risk factors. Washington (DC): Oxford University Press and the World Bank. 45-93.
    7.Spearman C W, Sonderup M W. (2015) Health disparities in liver disease in sub-Saharan Africa. Liver Int. Sep;35(9): 2063-71. doi: 10.1111/liv.12884. Epub 26053588.
    8. (2011) World Health Organization. Global Status Report on Alcohol and Health. , Geneva, Switzerland:
    9.Paula H, Asrani S K, Boetticher N C, Pedersen R, Shah V H et al. (2010) Alcoholic liver disease-related mortality in the United States1980-2003. , Am J Gastroenterol 105(8), 1782-7.
    10.Bray F, Ferlay J, Soerjomataram I, Siegel R L, Torre L A et al. (2018) Global cancer statistics2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , CA Cancer J Clin 68, 394-424.
    11.Petrick J L, Florio A A, Znaor A, Ruggieri D, Laversanne M et al. (2019) International trends in hepatocellular carcinoma incidence. , Int J Cancer 1978-2012.
    12.Sgro C, Clinard F, Ouazir K. (2002) Incidence of drug-induced hepatic injuries: a French population-based study. , Hepatology 36, 451-455.
    13.Björnsson E S, Bergmann O M, Björnsson H K, Kvaran R B, Olafsson S. (2013) Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. , Gastroenterology 144, 1419-1425.
    14.Tsega E. (1977) Current views on liver diseases in Ethiopia. Ethiop Med J. 15(2), 75-82.
    15.Abdelmenan S, Banes A, Berhane Y, Abebe M, Wandall J H.Etiology of Chronic Liver Disease in Ethiopia: A Case Control Study with Special Reference to Viral Hepatitis and Alcohol. EC Gastroenterol Dig Syst. 2018 Mar;5(3): 120-128. Epub 2018 Feb 6. PMID: 30854518; PMCID: PMC6402780 .
    16.Orlien. (2018) . , BMC Gastroenterology 18-27.
    17.Melato M, Sasso F, Zanconati F. (1993) Liver cirrhosis and liver cancer. A study of their relationship in2563 autopsies. Zentralbl Pathol. 139, 25-30.
    18.Graudal N, Leth P, Marbjerg L, Galloe A M. (1991) Characteristics of cirrhosis undiagnosed during life: a comparative analysis of 73 undiagnosed cases and 149 diagnosed cases of cirrhosis, detected in4929 consecutive autopsies. , J Intern Med 230, 165-171.
    19.Lim Y S, Kim W R. (2008) The global impact of hepatic fibrosis and end-stage liver disease. Clin Liver Dis. 12, 733-746.
    20.Tsega E, Nordenfelt E, Hansson B G, Mengesha B, Lindberg J. (1992) Chronic liver disease in Ethiopia: a clinical study with emphasis on identifying common causes. Ethiopian Medical Journal. Apr;30(2 Suppl):
    21.Ali et al. AJOAIMS, 202033... 2(3), 1-6.
    22.Schweitzer A, Horn J, Mikolajczyk R T, Krause G, Ott J J. (2015) Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between1965and2013. , Lancet 386, 1546-55.
    23.Belyhun Y, Maier M, Mulu A, Diro E, Liebert U G. (2016) Hepatitis viruses in Ethiopia:a systematic review and meta-analysis. BMC Infect Dis. 16-761.
    24.Prevalence. (2013) Risk Factors of Hepatitis B and Hepatitis C. Virus Infections among Patients with Chronic Liver Diseases in Public Hospitals in Addis Ababa, Ethiopia : ISRN Tropical Medicine, Article ID 563821 7.
    25.Belyhun Y, Maier M, Mulu A, Diro E, Liebert U G. (2016) Hepatitis viruses in Ethiopia:a systematic review and meta-analysis. BMC Infect Dis. 16-761.
    26.Pishvaian A C, Trope B W, Lewis J H. (2004) Drug-induced liver disease in 2003. Curr Opin Gastroenterol. 20(3), 208-19.
    27.Tyson G L, Kramer J R, Duan Z, Davila J A, Richardson P A et al. (2013) Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients. , Hepatology 58, 538-545.
    28.Mekonnen H D, Sharma S, Shewaye A, Feld J, Lulu E. (2015) Major Risk Factors, Clinical and Laboratory Characteristics of Patients With Hepatocellular Carcinoma; A Retrospective Study At Tikur Anbassa Hospital. , Addis Ababa University, Addis Ababa, Ethiopia. Ethiop Med J 53(3), 127-32.
    29.Arshad C, Dutta T, A Thakral Choudhury. (2018) Liver Disease Detection Due to Excessive Alcoholism Using Data Mining Techniques. International Conference on Advances in Computing and Communication Engineering (ICACCE) 163-168.
    30.Karel J, Erpecum Van. (2006) Ascites and spontaneous bacterial peritonitis in patients with liver cirrhosis. , Scandinavian Journal of Gastroenterology 41(243), 79-84.